Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06593353 · ClinicalTrials.gov registry record · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
A NA study of Opioid Use Disorder and Opioid Use Disorders, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 4,165
- Enrollment target
- 1
- Study location
NCT06593353: Recruiting NA study of Opioid Use Disorder and Opioid Use Disorders, sponsored by University of Washington.
NCT06593353 is a NA study of Opioid Use Disorder and Opioid Use Disorders that is actively recruiting participants, run by University of Washington. The registered enrollment target is 4,165 participants, below the 4,640-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06593353, a NA study of Opioid Use Disorder and Opioid Use Disorders, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,165 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effectiveness of a health systems strategy (the Systems Analysis and Improvement Approach - SAIA) that packages systems engineering tools (including cascade analysis, flow mapping, and continuous quality improvement) to optimize the management of opioid use disorder (MOUD) care cascade and improve linkages between jails and clinical referral sites. The investigators will 1. study the effectiveness of SAIA on MOUD care cascade quality and continuity for patients receiving care in jail and exiting to referral clinics 2. explore determinants of adoption, implementation, and sustainment of SAIA-MOUD across implementation clinics, and 3. estimate the cost and cost-effectiveness of SAIA-MOUD
Primary Outcome
the proportion of individuals exiting jails in King County on MOUD who link to any MOUD clinical provider in the community within 30 days
Conditions Studied
Interventions
- OTHER Systems Analysis and Improvement Approach (SAIA)
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,165 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06593353 shows while recruiting
NCT06593353 is an interventional study that assigns participants to a tested intervention. Its 4,165 participants enrollment target places it among the larger protocols in the corpus, below the 4,640-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (10% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Systems Analysis and Improvement Approach (SAIA) is the first listed.
NCT06593353 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06593353 about?
NCT06593353 is a clinical study titled "Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail". This study evaluates the effectiveness of a health systems strategy (the Systems Analysis and Improvement Approach - SAIA) that packages systems engineering tools (including cascade analysis, flow mapping, and continuous quality improvement) to optimize the management of opioid use disorder (MOUD) c...
What is the current status of trial NCT06593353?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,165 participants. The study started on 2024-11-21. Estimated completion is 2028-06-30.
What conditions does trial NCT06593353 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use Disorders.
What interventions are being tested in trial NCT06593353?
The interventions under investigation include: Systems Analysis and Improvement Approach (SAIA) (OTHER).
Who is sponsoring clinical trial NCT06593353?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06593353 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06593353's enrollment target sits among peer trials
4,165 9th of 257 higher than 249 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
-
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI